SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14762)9/19/2000 7:06:45 PM
From: aknahow  Read Replies (2) | Respond to of 17367
 
Cacaito, all is forgotten, you are a true friend. My other friends did not supply 1/100 of this information. I am never going to speak to them again. Just going to forgive them. <g>

BTW someone claiming to be Manfred e-mailed me asking me to tell Bluegreen that, "Switzerland is much more advanced than the U.S. When we cure Baboons, we don't give them computers and allow them to post, as you apparently do in your country."



To: Cacaito who wrote (14762)9/19/2000 11:09:56 PM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
Overall an excellent study both in design an execution under the circumstances of big logistical problems like recruitment of patients in a disease that is rare, early use of the drug is imperative, rapidity of disease progression, informed consent, and the need for "slow infusion" of the drug.
>>cacaito, you have made several excellent observations tonight.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News